US listing tips – new factsheet from Nasdaq and Baker McKenzie

Interest from Swedish listed companies in dual listing in the US has increased significantly. Every year, around 15 European companies choose to list on Nasdaq USA, and in recent years we have seen increased interest in a Nasdaq USA listing from the Nordic region. With Ymab, Orphazyme, Calliditas and most recently Galecto as examples. These companies have chosen to list via a traditional IPO or a dual listing combined with a capital raising aimed at both US and Nordic investors. Are you considering a US listing? The factsheet gives you valuable tips.

The fact sheet can be found here